Clinical Trial Update: A Clinical Study to Evaluate the Efficacy and Safety of HLX07 Combination Therapy in Patients With Extensive Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical study evaluating HLX07 in combination therapy for extensive small cell lung cancer; current status unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• HLX07 (HLX07)

Snippet

Sponsor: Shanghai Henlius Biotech | Conditions: Small-cell Lung Cancer | Phase 2 | Status: UNKNOWN